Home

Richard E. Lowenthal, President and CEO: ARS Pharmaceuticals SPRY Planned sale · Filed 08/18

Trade details

Type
Planned sale notice
Planned sale date
26/08/18
Filed
26/08/18

$315.9K to be sold

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 07/19~09/17

Richard E. Lowenthal's recent trades

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $177K

    Filed 09/11

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $421.1K

    Filed 09/04

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $115.6K

    Filed 09/03

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $5,000

    Filed 09/02

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $148.2K

    Filed 08/20